Fusion Between Transcription Factor CBFβ/PEBP2β and a Myosin Heavy Chain in Acute Myeloid Leukemia
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The pericentric inversion of chromosome 16 [inv(16)(p13q22)] is a characteristic karyotypic abnormality associated with acute myeloid leukemia, most commonly of the M4Eo subtype. The 16p and 16q breakpoints were pinpointed by yeast artificial chromosome and cosmid cloning, and the two genes involved in this inversion were identified. On 16q the inversion occurred near the end of the coding region for CBFβ, also known as PEBP2β, a subunit of a heterodimeric transcription factor regulating genes expressed in T cells; on 16p a smooth muscle myosin heavy chain (SMMHC) gene (MYH11) was interrupted. In six of six inv(16) patient samples tested, an in-frame fusion messenger RNA was demonstrated that connected the first 165 amino acids of CBFβ with the tail region of SMMHC. The repeated coiled coil of SMMHC may result in dimerization of the CBFβ fusion protein, which in turn would lead to alterations in transcriptional regulation and contribute to leukemic transformation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A fourth alteration, inv (16), is observed in AML of the M4Eo subtype (French-American-British classification) and indirectly targets AML-1B by fusing CBF-, the gene for the heterodimeric DNA binding partner of AML-1B (71), to the smooth muscle myosin heavy chain gene, MYH11 (35,64).”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
In the citing paper
“Consistent with the hypothesis that the inv(16) product titrates AML-1B through physical interactions (35), CBF-- MYH11 represses AML-1B-dependent activation but has only minimal effects on C/EBP-␣.”
From The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation (1998) · cites this paper as [35]
Citations
Cites
BENNETT, J. M., CATOVSKY, D., DANIEL, M. T., FLANDRIN, G., GALTON, D. A. G., GRALNICK, H. R., & SULTAN, C. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-4-620 · Cited by 2,926
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
Martin-Zanca, D., Hughes, S. H., & Barbacid, M. (1986) · Nature · doi:10.1038/319743a0 · Cited by 803
Translocations Among Antibody Genes in Human Cancer
Leder, P., Battey, J., Lenoir, G., Moulding, C., Murphy, W., Potter, H., Stewart, T., & Taub, R. (1983) · Science · doi:10.1126/science.6356357 · Cited by 712
Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17
Borrow, J., Goddard, A. D., Sheer, D., & Solomon, E. (1990) · Science · doi:10.1126/science.2218500 · Cited by 632
Ogawa, E., Maruyama, M., Kagoshima, H., Inuzuka, M., Lu, J., Satake, M., Shigesada, K., & Ito, Y. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6859 · Cited by 608
Ogawa, E., Inuzuka, M., Maruyama, M., Satake, M., Naito-Fujimoto, M., Ito, Y., & Shigesada, K. (1993) · Virology · doi:10.1006/viro.1993.1262 · Cited by 493
Le Beau, M. M., Larson, R. A., Bitter, M. A., Vardiman, J. W., Golomb, H. M., & Rowley, J. D. (1983) · New England Journal of Medicine · doi:10.1056/nejm198309153091103 · Cited by 492
Wang, S., Wang, Q., Crute, B. E., Melnikova, I. N., Keller, S. R., & Speck, N. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3324-3339.1993 · Cited by 435
Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia.
Rowley, J. D. (1973) · PubMed · Cited by 366
Research works printed but not linked: 1
- CALLEN, D.F., Precise localisation of the long arm breakpoint on the inv(16) of ANNL M4Eo and progress towards cloning this breakpoint, AMERICAN JOURNAL OF HUMAN GENETICS 51: A57 (1992).
Cited by
Items 501–600 of 778
The promise of omics-based approaches to cancer prevention
Meerzaman, D. M., Dunn, B. K., Lee, M. Y., Chen, Q., Yan, C., & Ross, S. A. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.09.004 · Cited by 12
Maki, K., Sasaki, K., Sugita, F., Nakamura, Y., & Mitani, K. (2012) · International Journal of Hematology · doi:10.1007/s12185-012-1112-z · Cited by 12
Richter, L. E., Wang, Y., & Hyde, R. K. (2016) · Oncotarget · doi:10.18632/oncotarget.11357 · Cited by 12
Structure and Biophysics of CBFβ/RUNX and Its Translocation Products
Tahirov, T. H., & Bushweller, J. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_2 · Cited by 12
Core Binding Factor β (CBFβ) Is Retained in the Midbody During Cytokinesis
López‐Camacho, C., van Wijnen, A. J., Lian, J. B., Stein, J. L., & Stein, G. S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24588 · Cited by 12
Batanian, J. R., Huang, Y.-F., & Fallon, R. J. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00251-x · Cited by 12
Hematological features and treatment outcome in acute myeloid leukemia with t(8;21)
Ma, S. K., Au, W. Y., Kwong, Y., Lam, C. K., Liang, R. H. S., & Ha, S. (1997) · Hematological Oncology · doi:10.1002/(sici)1099-1069(199705)15:2<93::aid-hon603>3.0.co;2-g · Cited by 12
Finn, W. G., & Peterson, L. C. (2004) · Kluwer Academic Publishers eBooks · doi:10.1007/b113185 · Cited by 12
Hirose, Y., Sato, S., Hashiya, K., Bando, T., & Sugiyama, H. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c00613 · Cited by 11
Application of DNA‐Alkylating Pyrrole‐Imidazole Polyamides for Cancer Treatment
Maeda, R., Bando, T., & Sugiyama, H. (2021) · ChemBioChem · doi:10.1002/cbic.202000752 · Cited by 11
Acute Myeloid Leukemia in Adults
Appelbaum, F. R. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50108-1 · Cited by 11
Huh, J., Kim, H., Jung, C. W., Kim, H., Kim, S. H., Kim, Y., Kim, H., Shin, M., Moon, J. H., Sohn, S. K., et al. (2012) · American Journal of Hematology · doi:10.1002/ajh.23281 · Cited by 11
Achkar, W. A., Wafa, A., Mkrtchyan, H., Moassass, F., & Liehr, T. (2010) · Molecular Cytogenetics · doi:10.1186/1755-8166-3-6 · Cited by 11
Serrano, E., Carnicer, M. J., Lasa, A., Orantes, V., Peña, J., Brunet, S., Aventin, A. M., Sierra, J., & Nomdedeu, J. F. (2008) · Leukemia Research · doi:10.1016/j.leukres.2007.11.038 · Cited by 11
Novel Naphthalene Derivatives as Inhibitors of Human Immunoglobulin E Antibody Production
Hasegawa, M., Takenouchi, K., Takahashi, K., Takeuchi, T., Komoriya, K., Uejima, Y., & Kamimura, T. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm9605041 · Cited by 11
Hegde, M. B., Ahmad, M. H., Mulet‐Lazaro, R., Sugita, M., Li, R., Hu, K., Gebhard, C., Guzmán, M. L., Bushweller, J. H., Zhu, L. J., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02471-9 · Cited by 10
Zhao, W., Claxton, D. F., Medeiros, L. J., Lü, D., Vadhan‐Raj, S., Kantarjian, H. M., Nguyen, M. H., & Bueso-Ramos, C. (2006) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213301.19273.66 · Cited by 10
Self-citationDauwerse, H. G., Smit, E. M. E., Giles, R. H., Slater, R. M., Breuning, M. H., Hagemeijer, A., & van der Reijden, B. A. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01521.x · Cited by 10
Fujioka, M., Yusibova, G. L., Sackerson, C., Tillib, S. V., Mazo, A., Satake, M., Goto, T., & Suzuki, Y. (1996) · Genes to Cells · doi:10.1111/j.1365-2443.1996.tb00014.x · Cited by 10
Rowe, D., Strain, L., Lowe, C., & Jones, G. (2007) · Haematologica · doi:10.3324/haematol.11536 · Cited by 10
Solution properties of the free and DNA‐bound Runt domain of AML1
Wolf‐Watz, M., Xie, X., Holm, M., Grundström, T., & Härd, T. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00269.x · Cited by 10
Martinez-Climent, J. A., Comes, A. M., Vizcarra, E., Reshmi, S. C., Benet, I., Marugán, I., Tormo, M., Terol, M. J., Solano, C., Arbona, C., et al. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00187-3 · Cited by 10
KOPF, E., & MISKIN, R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01510.x · Cited by 9
Zhang, L., Zhang, L., Shi, Z., Mi, Y., Zhang, L., Shi, X., Gao, S., & Zuo, L. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338241305434 · Cited by 9
Diemer, J. L., Yu, K., Kelly, M. C., Zhen, T., Anderson, S. M., Lopez, G., & Liu, P. (2023) · Leukemia · doi:10.1038/s41375-023-01926-9 · Cited by 9
Self-citationCbfβ: A key regulator in skeletal stem cell differentiation, bone development, and disease
Zheng, C., Zhang, C., He, Y., Lin, S., Zhu, Z., Wang, H., & Chen, G. (2025) · The FASEB Journal · doi:10.1096/fj.202500030r · Cited by 9
Bain, B. J. (2017) · Wiley eBooks · doi:10.1002/9781119210511.ch3 · Cited by 9
RUNX1 colludes with NOTCH1 to reprogram chromatin in T cell acute lymphoblastic leukemia
Islam, M. R., Jenkins, C. E., Cao, Q., Wong, J., Bilenky, M., Carles, A., Moksa, M., Weng, A. P., & Hirst, M. (2023) · iScience · doi:10.1016/j.isci.2023.106795 · Cited by 9
Zhang, L., D’Costa, J., Kummalue, T., Civin, C. I., & Friedman, A. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209725 · Cited by 9
Acute myeloid leukemia and related precursor neoplasms
Lorsbach, R. B. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781292.016 · Cited by 9
Transcription therapy for acute promyelocytic leukaemia
Douer, D. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.2.329 · Cited by 9
Harrison, C. J., & Secker‐Walker, L. M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80013-7 · Cited by 9
Identification of the inverted chromosome 16 using chromosome painting
Rao, P. N., Flejter, W. L., Rahi, S., Li, H., & Pettenati, M. J. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01228.x · Cited by 9
Pathobiology of Acute Myeloid Leukemia
Brunner, A. M., & Graubert, T. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-35762-3.00058-5 · Cited by 9
Hirose, Y., Sato, S., Hashiya, K., Ooga, M., Bando, T., & Sugiyama, H. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00315 · Cited by 8
Nann, D., Schade, T., Overkamp, M., Mahmutovic, L., Bag, E., Forchhammer, S., Slotta‐Huspenina, J., Boudová, L., Sotlar, K., Quintanilla‐Martínez, L., et al. (2025) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70044 · Cited by 8
Crane‐Heise syndrome: A second familial case report with elaboration of phenotype
Zand, D. J., Carpentieri, D. F., Huff, D. S., Medne, L., Napierala, D., Lee, B., & Zackai, E. H. (2003) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.10026 · Cited by 8
Molecular Analysis of a New Variant of the CBFβ - MYH11 Gene Fusion
Stulberg, J., Kamel‐Reid, S., Chun, K., Tokunaga, J., & Wells, R. A. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000015989-1 · Cited by 8
Liu, H., Cui, Y. T., Wang, G., Dong, Q., Yao, Y., Li, P., Cao, C., & Liu, X. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.05.001 · Cited by 8
An updated account on molecular heterogeneity of acute leukemia.
Rahul, E., Goel, H., Chopra, A., Ranjan, A., Gupta, A. K., Meena, J. P., Bakhshi, S., Misra, A., Hussain, S., Viswanathan, G. K., et al. (2021) · American Journal of Blood Research · Cited by 8
Quesada, A. E., Luthra, R., Jabbour, E. J., Patel, K. P., Khoury, J. D., Tang, Z., Alvarez, H., Mallampati, S., Garcia‐Manero, G., Bravo, G. M., et al. (2021) · Molecular Case Studies · doi:10.1101/mcs.a006084 · Cited by 8
Usuki, K., Nakatsu, M., Kitazume, K., Endo, M., OSAWA, M., Iki, S., Arai, M., & Urabe, A. (1996) · Internal Medicine · doi:10.2169/internalmedicine.35.327 · Cited by 8
Jakubowiak, A. J., Cammenga, J., Sokolic, R. A., Álvarez, S., Jackson, G., Hedvat, C. V., & Nimer, S. D. (2000) · Current Oncology Reports · doi:10.1007/s11912-000-0083-z · Cited by 8
Fluoreszenz-in-situ-Hybridisierung (FISH): Methodik und Anwendung
Fischer, K., Bentz, M., & Döhner, H. (1997) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03045083 · Cited by 8
Efficient and precise inversion of genomic DNA from large to chromosomal scale
Zhang, A., Sun, X., Wu, Y. X., Gao, P., Zhang, R., Zhang, M., Xie, S., Fan, W., Zhang, Y., & Yin, H. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-02033-9 · Cited by 7
Zhao, L., Alkadi, H. S., Kwon, E. M., Zhen, T., Lichtenberg, J., Alemu, L., Cheng, J., Friedman, A. D., & Liu, P. P. (2017) · Leukemia · doi:10.1038/leu.2017.262 · Cited by 7
Self-citationNeto, W. K., Serpa, M. G., Sanabani, S. S., Bueno, P. T., Velloso, E. D. R. P., Dorlhiac‐Llacer, P. E., & Bendit, I. (2010) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s6446 · Cited by 7
van der Reijden, B. A., Massop, M., Simons, A., de Witte, T., Breuning, M. H., & Jansen, J. H. (2010) · Leukemia · doi:10.1038/leu.2009.290 · Cited by 7
Kobayashi, H., Satake, N., & Kaneko, Y. (1997) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199709058329 · Cited by 7
Leukemias, Lymphomas, and Other Related Disorders
Zhang, Y., & Rowley, J. D. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00079-3 · Cited by 7
CROX (Cluster Regulation of RUNX) as a Potential Novel Therapeutic Approach.
Kamikubo, Y. (2020) · PubMed Central · doi:10.14348/molcells.2019.0268 · Cited by 7
Differentiation or leukemia: Is C/EBPα the answer?
Hiebert, S. W. (2001) · Nature Medicine · doi:10.1038/86461 · Cited by 7
Detection of minimal residual disease
Deptała, A., & Mayer, S. P. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)64023-8 · Cited by 7
Mutational Analyses of the AML1 Gene in Patients with Myelodysplastic Syndrome
Imai, Y., Kurokawa, M., Izutsu, K., Hangaishi, A., Maki, K., Ogawa, S., Chiba, S., Mitani, K., & Hirai, H. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290012155 · Cited by 7
Li, S., Couzi, R. J., Thomas, G. H., Friedman, A. D., & Borowitz, M. J. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00360-5 · Cited by 7
Acute Myelomonoblastic Leukemia Carrying the PEBP2β/MYH11 Fusion Gene
Asou, N., Osato, M., Okubo, T., Yamasaki, H. R., Hoshino, K., Nishimura, S., Era, T., Suzushima, H., & Takatsuki, K. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809057587 · Cited by 7
Suvannasankha, A., Minderman, H., O’Loughlin, K. L., Sait, S. N. J., Stewart, C. C., Greco, W. R., & Baer, M. R. (2003) · Leukemia Research · doi:10.1016/j.leukres.2003.09.003 · Cited by 7
Chromosome 16 Inversion-Associated Translocation
Maarek, O., Salabelle, A., Coniat, M. L., Daniel, M., & Berger, R. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00059-x · Cited by 7
Sameeta, F., Wang, S. A., Tang, Z., Khoury, J. D., Fang, H., Wang, D., Xu, J., Li, S., Hu, Z., Hu, S., et al. (2024) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqae060 · Cited by 6
Akiyama, H., Yamamoto, M., Sakashita, C., Umezawa, Y., Kurosu, T., Murakami, N., & Miura, O. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3535 · Cited by 6
Molecular Basis and Targeted Inhibition of CBFβ-SMMHC Acute Myeloid Leukemia
Castilla, L. H., & Bushweller, J. H. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_15 · Cited by 6
The oncogenic fusion protein CBFB-SMMHC downregulates CD48 to evade NK cell recognition
Kahlon, S., Shreibman, D., Unger, T., Ben‐Yehuda, D., & Elias, S. (2018) · Blood Cancer Journal · doi:10.1038/s41408-018-0082-7 · Cited by 6
Insights into Acute Myeloid Leukemia: Critical Analysis on its Wide Aspects
(2020) · Abasyn Journal Life Sciences · doi:10.34091/ajls.3.2.1 · Cited by 6
Chromosomes and Chromosomal Instability in Human Cancer
Ohyashiki, K., Kuroda, M., & Ohyashiki, J. H. (2016) · Springer eBooks · doi:10.1007/978-1-59745-458-2_15 · Cited by 6
Acute myeloid leukemia in a child with hereditary thrombocytopenia
Rheingold, S. R. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20677 · Cited by 6
Mouse Models of Human Blood Cancers: Basic Research and Pre-clinical Applications
Li, S. (2008) · Springer eBooks · doi:10.1007/978-0-387-69132-9 · Cited by 6
Blepharochalasis: A rare cause of eye swelling
Paul, M., Geller, L., & Nowak-Wegrzyn, A. H. (2017) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2017.07.036 · Cited by 6
The Roles of RUNX Proteins in Lymphocyte Function and Anti-Tumor Immunity
Seo, W., Nomura, A., & Taniuchi, I. (2022) · Cells · doi:10.3390/cells11193116 · Cited by 6
Hussain, S. R., Naqvi, H., Mahdi, F., Bansal, C., & Gosipatala, S. B. (2012) · Molecular Biotechnology · doi:10.1007/s12033-012-9584-x · Cited by 6
Head, D., & Thompson, M. A. (2007) · Springer eBooks · doi:10.1007/978-3-540-72304-2_2 · Cited by 6
Introduction: Childhood Leukemia
Medina‐Sansón, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-05798-9_1 · Cited by 6
Park, H. J., Lee, K. E., Um, J. M., Choe, S. Y., Chi, X. Z., Lee, J. A., Shin, H. Y., Ahn, H. S., & Bae, S. (2000) · Molecules and Cells · doi:10.1007/s10059-000-0090-9 · Cited by 6
Monosomy 16 as the Sole Abnormality in Myeloid Malignancies
McGhee, E. M., Cohen, N. R., Wolf, J. L., Ledesma, C. T., & Cotter, P. D. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00194-6 · Cited by 6
10 Factors involved in leukaemogenesis and haemopoiesis
Elefanty, A. G., Robb, L. G., & Begley, C. G. (1997) · Baillière s Clinical Haematology · doi:10.1016/s0950-3536(97)80028-5 · Cited by 6
Starza, R. L., Wlodarska, I., Matteucci, C., Falzetti, D., Baens, M., Martelli, M. F., den Berghe, H. V., Marynen, P., & Mecucci, C. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199809)23:1<10::aid-gcc2>3.0.co;2-9 · Cited by 6
Heerema, N. A. (1998) · Cancer Investigation · doi:10.3109/07357909809039765 · Cited by 6
Constitutional Balanced Pericentric Inversions of Chromosomes X, 2, and 5 in Myeloid Malignancies
Mozziconacci, J., Sobol, H., Philip, N., Stoppa, A., Brunel, V., Granel, B., Blaise, D., Sainty, D., Birnbaum, D., & Lafage‐Pochitaloff, M. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00087-9 · Cited by 6
CBFβ-SMMHC–driven leukemogenesis requires enhanced RUNX1-DNA binding affinity in mice
Zhen, T., Cao, Y., Dou, T., Chen, Y., Lopez, G., Menezes, A. C., Wu, X., Hammer, J. A., Cheng, J., Garrett, L. J., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci192923 · Cited by 5
Self-citationMinimal Residual Disease in Acute Myeloid Leukemia: RT-PCR-Based Studies of Fusion Transcripts
Marcucci, G., & Caligiuri, M. A. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-318-7_9 · Cited by 5
Acute myeloid leukemia with cryptic CBFB-MYH11 type D.
Kobayashi, T., Ichikawa, M., Kamikubo, Y., & Kurokawa, M. (2013) · Europe PMC (PubMed Central) · Cited by 5
Coexistence of p210BCR‑ABL and CBFβ‑MYH11 fusion genes in myeloid leukemia: A report of 4 cases
Wang, Y. Y., Ding, W., Jiang, F., Chen, Z., Cen, J., Qi, X., Liang, J., Liu, D., Pan, J., & Chen, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.6812 · Cited by 5
Tang, G., Zou, Y. S., Wang, S. A., Borthakur, G. M., Törüner, G., Hu, S., Li, S., Xu, J., Medeiros, L. J., & Tang, Z. (2022) · Annals of Hematology · doi:10.1007/s00277-022-04767-1 · Cited by 5
Application à l’hématologie maligne des techniques de biologie moléculaire
Delabesse, É., Asnafi, V., & Macintyre, E. A. (2003) · Transfusion Clinique et Biologique · doi:10.1016/s1246-7820(03)00105-8 · Cited by 5
Yamamoto, K., Nishikawa, S., Minagawa, K., Yakushijin, K., Okamura, A., & Matsui, T. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.08.001 · Cited by 5
Spencer, D. V., Cavalier, M., Kalpatthi, R. V., & Quigley, D. I. (2007) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2007.08.007 · Cited by 5
Deletion of the long arm of chromosome 7 in myelomonocytic leukemia with bone marrow eosinophilia
Davidovitz, Y., Zimlichman, R., Rosner, E., Berkowic, M., Ballin, A., & Meytes, D. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00391-3 · Cited by 5
A novel t(16;20)(q22;p13) in polycythemia vera
Daibata, M., Taguchi, T., & Taguchi, H. (2002) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00543-5 · Cited by 5
Martinelli, G., Ottaviani, E., Buonamici, S., Isidori, A., Malagola, M., Piccaluga, P. P., & Baccarani, M. (2002) · PubMed · Cited by 5
A comprehensive analysis of cancer-driving mutations and genes in kidney cancer
Long, C., Jian, J., Li, X., Wang, G., & Wang, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.5689 · Cited by 5
Stallings, R. L., & Bianchi, D. W. (1994) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320520318 · Cited by 5
Hematopoietic Growth Factors in Leukemia
Touw, I. P., & Dong, F. (1996) · Pathology - Research and Practice · doi:10.1016/s0344-0338(96)80095-1 · Cited by 5
Naidu, V. M., Rawat, V. P. S., Schessl, C., Petropoulus, K., Cusan, M., Deshpande, A. J., Martínez, L. Q., Hiddemann, W., Feuring‐Buske, M., & Buske, C. (2008) · Blood · doi:10.1182/blood.v112.11.928.928 · Cited by 5
The Role of the Immune System in Anti-Tumour Responses: Potential for Drug Therapy
Dermime, S., Barrett, J. A., & Gambacorti-Passerini, C. B. (1995) · Drugs & Aging · doi:10.2165/00002512-199507040-00002 · Cited by 5
Duployez, N., & Preudhomme, C. (2025) · Seminars in Hematology · doi:10.1053/j.seminhematol.2025.06.001 · Cited by 4
Molecular diagnostics of acute myeloid leukaemia
Zuo, Z., Chandra, P., Wen, Y. H., & Koeppen, H. (2009) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2009.08.004 · Cited by 4
Gene Transcription as a Therapeutic Target in Leukemia
Khamidullina, A. I., Varlamova, E. A., Hammoud, N. A., Yastrebova, M. A., & Bruter, A. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147340 · Cited by 4
Rubnitz, J. E., Inaba, H., & Ribeiro, R. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977633.017 · Cited by 4
Yin, C. C., Jones, D. M., Cortes, J. E., Kantarjian, H. M., Merzianu, M., Medeiros, L. J., & Bueso-Ramos, C. (2008) · Clinical Leukemia · doi:10.3816/clk.2008.n.035 · Cited by 4
Transforming Properties of the Leukemic Inv(16) Fusion Gene CBFB-MYH11
Hajra, A. K., Liu, P. P., & Collins, F. S. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_29 · Cited by 4
Self-citationMolecular genetics of acute myeloid leukemia
Lorsbach, R. B., & Downing, J. R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.012 · Cited by 4
Metadata
- Authors
- Liu, P., Tarlé, S. A., Hajra, A., Claxton, D. F., Marlton, P., Freedman, M., Siciliano, M. J., & Collins, F. S.
- Affiliations
- Howard Hughes Medical Institute (US)
- The University of Texas MD Anderson Cancer Center (US)
- Venue
- Science
- Published
- 1993-08-20
- Volume
- 261
- Issue
- 5124
- Pages
- 1041-1044
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2047591593
- Cited by
- 732
- References
- 37
- Citations by year
- 2026: 8 · 2025: 7 · 2024: 7 · 2023: 9 · 2022: 11 · 2021: 12 · 2020: 15 · 2019: 13 · 2018: 8 · 2017: 24 · 2016: 8 · 2015: 23 · 2014: 18 · 2013: 14 · 2012: 15
- FWCI
- 25.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA-55164, P01CA055164)
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- acute myeloid leukemia, inv(16)(p13q22), CBFβ, smooth muscle myosin heavy chain, MYH11, gene fusion, transcription factors, coiled-coil dimerization, leukemic transformation, karyotype abnormalities
- MeSH terms
- Amino Acid Sequence, Base Sequence, Chromosomes, Human, Pair 16, Cloning, Molecular, Cosmids, DNA-Binding Proteins, Humans, Chromosome Inversion, Molecular Sequence Data, Muscle, Smooth, Myosins, Neoplasm Proteins, Transcription Factors, Restriction Mapping, Leukemia, Myelomonocytic, Acute, Polymerase Chain Reaction, In Situ Hybridization, Fluorescence, Transcription Factor AP-2, Core Binding Factor beta Subunit, Core Binding Factor Alpha 1 Subunit, Core Binding Factors, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.